Clinical Trials Directory

Trials / Completed

CompletedNCT02014142

A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

A Phase 2 Single-Masked, Randomized Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
86 (actual)
Sponsor
Mati Therapeutics Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Determine efficacy of the latanoprost punctal plug. Effect of configuration of L-PPDS placement on efficacy will also be examined.

Conditions

Interventions

TypeNameDescription
DRUGLatanoprost Punctal Plug Delivery System (L-PPDS)Latanoprost Punctal Plug Delivery System (L-PPDS)

Timeline

Start date
2013-12-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2013-12-18
Last updated
2017-01-18

Locations

18 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02014142. Inclusion in this directory is not an endorsement.